Citalopram Solution
NDC Package 62135-540-24
Package Information
Citalopram solution is citalopram is used to treat depression. This formulation utilizes a solution delivery system. Marketed by Chartwell Rx, Llc, this product is identified by NDC 62135-540 and is authorized under FDA application ANDA077629.
Identification & Billing
- RxCUI: 309313 - citalopram 10 MG in 5 mL Oral Solution
- RxCUI: 309313 - citalopram 2 MG/ML Oral Solution
- RxCUI: 309313 - citalopram (as citalopram hydrobromide) 2 MG/ML Oral Solution
- RxCUI: 309313 - citalopram 10 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62135 - Chartwell Rx, Llc
- 62135-540 - Citalopram
- 62135-540-24 - 2 TRAY in 1 BOX / 10 CUP in 1 TRAY / 10 mL in 1 CUP (62135-540-10)
- 62135-540 - Citalopram
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (62135-540). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62135-540-24 identifies a specific commercial package of 2 tray in 1 box / 10 cup in 1 tray / 10 ml in 1 cup (62135-540-10) of Citalopram, a human prescription drug labeled by Chartwell Rx, Llc. This solution is formulated for oral use and contains citalopram hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chartwell Rx, Llc on June 14, 2006. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Citalopram is used to treat depression. It may improve your energy level and feelings of well-being. Citalopram is known as a selective serotonin reuptake inhibitor (SSRI). This medication works by helping to restore the balance of a certain natural substance (serotonin) in the brain.
How is this Chartwell Rx, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62135054024. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.